{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fcv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Strong","contributions":[{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10060","date":"2023-12-15T17:00:00.000Z","role":"Approver"},{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10060","date":"2024-04-09T13:37:11.156Z","role":"Publisher"}],"curationReasons":{"id":"cg:NewCuration"},"evidence":[{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:02bac36f-3b8c-4704-b011-e1568726a29b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:02bac36f-3b8c-4704-b011-e1568726a29b","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"cggv:b3c508aa-ed6c-4746-86f8-446edce9be52","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.776C>T (p.Pro259Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375683182"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002342","obo:HP_0001272","obo:HP_0000750","obo:HP_0001332","obo:HP_0001263","obo:HP_0001270","obo:HP_0000054","obo:HP_0001252","obo:HP_0002307","obo:HP_0001250","obo:HP_0001257"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:d6a8dfb7-d335-479b-abb4-25bf929073f5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b3c508aa-ed6c-4746-86f8-446edce9be52"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/33443317","type":"dc:BibliographicResource","dc:abstract":"The Mediator multiprotein complex functions as a regulator of RNA polymerase II-catalyzed gene transcription. In this study, exome sequencing detected biallelic putative disease-causing variants in MED27, encoding Mediator complex subunit 27, in 16 patients from 11 families with a novel neurodevelopmental syndrome. Patient phenotypes are highly homogeneous, including global developmental delay, intellectual disability, axial hypotonia with distal spasticity, dystonic movements, and cerebellar hypoplasia. Seizures and cataracts were noted in severely affected individuals. Identification of multiple patients with biallelic MED27 variants supports the critical role of MED27 in normal human neural development, particularly for the cerebellum. ANN NEUROL 2021;89:828-833.","dc:creator":"Meng L","dc:date":"2021","dc:title":"MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia."}},"rdfs:label":"11-1"},{"id":"cggv:d6a8dfb7-d335-479b-abb4-25bf929073f5","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:d6a8dfb7-d335-479b-abb4-25bf929073f5_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:3809329d-4766-4337-92b0-1fef81843dcf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3809329d-4766-4337-92b0-1fef81843dcf","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.871G>A (p.Gly291Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5295505"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000518","obo:HP_0001270","obo:HP_0410263","obo:HP_0002376","obo:HP_0000486","obo:HP_0001251","obo:HP_0001263","obo:HP_0001272","obo:HP_0002342","obo:HP_0001344"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:4defe363-4f36-4a01-8947-4c70222f07e8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/37517035","type":"dc:BibliographicResource","dc:abstract":"MED27 is a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation. Biallelic MED27 variants have recently been suggested to be responsible for an autosomal recessive neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia. We further delineate the clinical phenotype of MED27-related disease by characterizing the clinical and radiological features of 57 affected individuals from 30 unrelated families with biallelic MED27 variants. Utilizing exome sequencing and extensive international genetic data sharing, 39 unpublished affected individuals from 18 independent families with biallelic missense variants in MED27 have been identified (29 females, mean age at last follow-up 17Â±12.4 years, range 0.1-45). Follow-up and hitherto unreported clinical features were obtained from the published 12 families. Brain MRI scans from 34 cases were reviewed. MED27-related disease manifests as a broad phenotypic continuum ranging from developmental and epileptic-dyskinestic encephalopathy to variable neurodevelopmental disorder with movement abnormalities. It is characterised by mild to profound global developmental delay/intellectual disability (100%), bilateral cataracts (89%), infantile hypotonia (74%), microcephaly (62%), gait ataxia (63%), dystonia (61%), variably combined with epilepsy (50%), limb spasticity (51%), facial dysmorphism (38%), and death before reaching adulthood (16%). Brain MRI revealed cerebellar atrophy (100%), white matter volume loss (76.4%), pontine hypoplasia (47.2%), and basal ganglia atrophy with signal alterations (44.4%). Previously unreported 39 affected individuals had seven homozygous pathogenic missense MED27 variants, five of which were recurrent. An emerging genotype-phenotype correlation was observed. This study provides a comprehensive clinical-radiological description of MED27-related disease, establishes genotype-phenotype and clinical-radiological correlations, and suggests a differential diagnosis with syndromes of cerebello-lental neurodegeneration and other subtypes of \"neuro-MEDopathies\".","dc:creator":"Maroofian R","dc:date":"2023","dc:title":"Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders."}},"rdfs:label":"F2: P1"},{"id":"cggv:4defe363-4f36-4a01-8947-4c70222f07e8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:4defe363-4f36-4a01-8947-4c70222f07e8_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:1bfe29f8-0b23-4e26-b822-59cf67b5d3c8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:1bfe29f8-0b23-4e26-b822-59cf67b5d3c8","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"cggv:abff85c7-63d8-4c05-9312-309182233817","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.689T>G (p.Ile230Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375687203"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002342","obo:HP_0002066","obo:HP_0410263","obo:HP_0001251","obo:HP_0000717","obo:HP_0001272","obo:HP_0001263","obo:HP_0000750","obo:HP_0002307","obo:HP_0001270","obo:HP_0011968","obo:HP_0001257"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:77984c1c-8395-4656-a1da-d61b5d114119_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:abff85c7-63d8-4c05-9312-309182233817"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F4: P1"},{"id":"cggv:77984c1c-8395-4656-a1da-d61b5d114119","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:77984c1c-8395-4656-a1da-d61b5d114119_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2064984b-c75a-4467-b27f-0544d4cfa890_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2064984b-c75a-4467-b27f-0544d4cfa890","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":[{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},{"id":"cggv:a2e9081d-4158-4ea4-9891-835b3315fd94","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.392_393del (p.Gln131LeufsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499219687"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001270","obo:HP_0000518","obo:HP_0002187","obo:HP_0001257","obo:HP_0001250","obo:HP_0000750","obo:HP_0002307","obo:HP_0001263","obo:HP_0001272","obo:HP_0001252","obo:HP_0001332"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:50a0e69b-4faf-487c-ab38-7a37fd37a0a8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},{"id":"cggv:8048d066-f9e1-447a-b932-a7cc2365ee05_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a2e9081d-4158-4ea4-9891-835b3315fd94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"}],"rdfs:label":"8-1"},{"id":"cggv:50a0e69b-4faf-487c-ab38-7a37fd37a0a8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:50a0e69b-4faf-487c-ab38-7a37fd37a0a8_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:8048d066-f9e1-447a-b932-a7cc2365ee05","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8048d066-f9e1-447a-b932-a7cc2365ee05_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e2a4f78f-b145-4bf7-876a-f5daccfc5a92_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e2a4f78f-b145-4bf7-876a-f5daccfc5a92","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":36,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001332","obo:HP_0001260","obo:HP_0001263","obo:HP_0030842","obo:HP_0001252","obo:HP_0000518","obo:HP_0002376","obo:HP_0001257","obo:HP_0002342","obo:HP_0000012","obo:HP_0001272","obo:HP_0000020"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:564fd4a1-828f-4512-a556-575f3f1fd2e8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},"rdfs:label":"6-1"},{"id":"cggv:564fd4a1-828f-4512-a556-575f3f1fd2e8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:564fd4a1-828f-4512-a556-575f3f1fd2e8_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:33a61caa-ef42-485e-8e00-f226ba56e8cb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:33a61caa-ef42-485e-8e00-f226ba56e8cb","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0002376","obo:HP_0001270","obo:HP_0000518","obo:HP_0002342","obo:HP_0001251","obo:HP_0001999","obo:HP_0001257","obo:HP_0001344","obo:HP_0001272","obo:HP_0001263"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:9daf3c54-11ee-4b76-8bf4-b87d7af5d234_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F9: P1"},{"id":"cggv:9daf3c54-11ee-4b76-8bf4-b87d7af5d234","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:9daf3c54-11ee-4b76-8bf4-b87d7af5d234_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:553da2af-e586-4286-ad4e-684a32dd8092_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:553da2af-e586-4286-ad4e-684a32dd8092","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.839C>T (p.Pro280Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5295513"}},"detectionMethod":"Also homozygous for SLC6A7 variant NM_014228.4: c.1186G>A (p.Gly396Ser) and MPPE1 variant NM_023075.5: c.985A>T (p.Arg329*) (no gene disease associations described in OMIM, ClinGen or GenCC)","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0002307","obo:HP_0001344","obo:HP_0001999","obo:HP_0010864","obo:HP_0000518","obo:HP_0001332","obo:HP_0001263","obo:HP_0001270","obo:HP_0000020","obo:HP_0001324","obo:HP_0001272","obo:HP_0002376","obo:HP_0002540","obo:HP_0001250","obo:HP_0011968","obo:HP_0410263"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:2eeedf78-6462-409a-a576-4584974ce699_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F27: P1"},{"id":"cggv:2eeedf78-6462-409a-a576-4584974ce699","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:2eeedf78-6462-409a-a576-4584974ce699_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0abf997b-487f-400a-9e11-4f813fca673c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0abf997b-487f-400a-9e11-4f813fca673c","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":[{"id":"cggv:07054d90-5031-46e4-b19f-629e37f62fe2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.682-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA200593924"}},{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010808","obo:HP_0000252","obo:HP_0001250","obo:HP_0001344","obo:HP_0001999","obo:HP_0001257","obo:HP_0002187","obo:HP_0002540","obo:HP_0001272","obo:HP_0001601","obo:HP_0001252","obo:HP_0002015","obo:HP_0001270","obo:HP_0001263","obo:HP_0001332","obo:HP_0002376","obo:HP_0000518"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:43289f16-9e6b-47be-888a-61fd5b78593e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:07054d90-5031-46e4-b19f-629e37f62fe2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},{"id":"cggv:f985c6d1-e514-4baa-be9a-f9dc52354efc_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"}],"rdfs:label":"2"},{"id":"cggv:43289f16-9e6b-47be-888a-61fd5b78593e","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:43289f16-9e6b-47be-888a-61fd5b78593e_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Canonical splicing variant adjacent to an in-frame exon"},{"id":"cggv:f985c6d1-e514-4baa-be9a-f9dc52354efc","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:f985c6d1-e514-4baa-be9a-f9dc52354efc_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:8ad0c46a-3b02-4bae-a869-b4b11dbc958e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:8ad0c46a-3b02-4bae-a869-b4b11dbc958e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001272","obo:HP_0001347","obo:HP_0001252","obo:HP_0001263","obo:HP_0001256","obo:HP_0002317","obo:HP_0012110","obo:HP_0410263","obo:HP_0000750","obo:HP_0001250","obo:HP_0000518","obo:HP_0001257"],"previousTesting":true,"previousTestingDescription":"Fragile X (normal)","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:7c10b423-17fe-430d-a158-79f101ca4e57_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F1: P1"},{"id":"cggv:7c10b423-17fe-430d-a158-79f101ca4e57","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:7c10b423-17fe-430d-a158-79f101ca4e57_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:08c82007-5c9c-4b01-b44b-ea9f9e57a8a8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:08c82007-5c9c-4b01-b44b-ea9f9e57a8a8","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":10,"allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001332","obo:HP_0001257","obo:HP_0001270","obo:HP_0001272","obo:HP_0001250","obo:HP_0002015","obo:HP_0002342","obo:HP_0001252","obo:HP_0001263","obo:HP_0000750"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:94b83a2b-c122-480e-84d8-da4b4c924a21_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},"rdfs:label":"9"},{"id":"cggv:94b83a2b-c122-480e-84d8-da4b4c924a21","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:94b83a2b-c122-480e-84d8-da4b4c924a21_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:3393977b-2409-4640-9008-9d1237582e12_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3393977b-2409-4640-9008-9d1237582e12","type":"Proband","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":9,"allele":{"id":"cggv:f89c7fb4-6a85-4f72-9d92-6c974db2d3c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.536A>C (p.His179Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375681725"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Brain MRI not performed","phenotypes":["obo:HP_0001344","obo:HP_0002540","obo:HP_0001263","obo:HP_0001252","obo:HP_0001999","obo:HP_0010864","obo:HP_0001270","obo:HP_0000518","obo:HP_0001250","obo:HP_0001332"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:23ad263b-6a29-4c36-8420-973d393061f0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f89c7fb4-6a85-4f72-9d92-6c974db2d3c6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F10: P1"},{"id":"cggv:23ad263b-6a29-4c36-8420-973d393061f0","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:23ad263b-6a29-4c36-8420-973d393061f0_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:c17006e6-10ed-461b-9129-91866c540ba4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:c17006e6-10ed-461b-9129-91866c540ba4","type":"Proband","allele":{"id":"cggv:94322506-1e55-463e-a3e5-833023481c68","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.567G>C (p.Met189Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375681642"}},"phenotypes":["obo:HP_0001263","obo:HP_0004322"],"sex":"Female","variant":{"id":"cggv:3035a1ca-de87-4d9b-9afd-dbf0b7613bea_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:94322506-1e55-463e-a3e5-833023481c68"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29165669","type":"dc:BibliographicResource","dc:abstract":"ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) is a freely available, public archive of human genetic variants and interpretations of their significance to disease, maintained at the National Institutes of Health. Interpretations of the clinical significance of variants are submitted by clinical testing laboratories, research laboratories, expert panels and other groups. ClinVar aggregates data by variant-disease pairs, and by variant (or set of variants). Data aggregated by variant are accessible on the website, in an improved set of variant call format files and as a new comprehensive XML report. ClinVar recently started accepting submissions that are focused primarily on providing phenotypic information for individuals who have had genetic testing. Submissions may come from clinical providers providing their own interpretation of the variant ('provider interpretation') or from groups such as patient registries that primarily provide phenotypic information from patients ('phenotyping only'). ClinVar continues to make improvements to its search and retrieval functions. Several new fields are now indexed for more precise searching, and filters allow the user to narrow down a large set of search results.","dc:creator":"Landrum MJ","dc:date":"2018","dc:title":"ClinVar: improving access to variant interpretations and supporting evidence."}},"rdfs:label":"Not reported"},{"id":"cggv:3035a1ca-de87-4d9b-9afd-dbf0b7613bea","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:3035a1ca-de87-4d9b-9afd-dbf0b7613bea_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:18ff1db6-9e54-4fc0-b5c1-940a16d2f379_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:18ff1db6-9e54-4fc0-b5c1-940a16d2f379","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"cggv:b3c508aa-ed6c-4746-86f8-446edce9be52"},{"id":"cggv:bb2bb08b-48a3-4e04-9fe1-9bf488951240","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.188T>G (p.Val63Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5295771"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0002015","obo:HP_0001272","obo:HP_0000750","obo:HP_0001250","obo:HP_0002317","obo:HP_0001999","obo:HP_0000708","obo:HP_0001270","obo:HP_0002307","obo:HP_0000164","obo:HP_0002342","obo:HP_0002870"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:aefe14c2-d92c-4550-9ac8-85cf858e5ecb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bb2bb08b-48a3-4e04-9fe1-9bf488951240"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},{"id":"cggv:5f3d0712-6a6d-4fd7-9a5c-f3f683fe1315_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b3c508aa-ed6c-4746-86f8-446edce9be52"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"}],"rdfs:label":"1"},{"id":"cggv:5f3d0712-6a6d-4fd7-9a5c-f3f683fe1315","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:5f3d0712-6a6d-4fd7-9a5c-f3f683fe1315_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:aefe14c2-d92c-4550-9ac8-85cf858e5ecb","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:aefe14c2-d92c-4550-9ac8-85cf858e5ecb_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:99c303a0-9f5b-496d-b65f-19b1d9c5ecff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:99c303a0-9f5b-496d-b65f-19b1d9c5ecff","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":4,"allele":{"id":"cggv:eb2950b6-8311-4cee-92a6-2cdf89892da0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.220_231del (p.Ser74_Val77del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2582342994"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001332","obo:HP_0001263","obo:HP_0001252","obo:HP_0001272","obo:HP_0002376","obo:HP_0001324","obo:HP_0002540","obo:HP_0000252","obo:HP_0001344","obo:HP_0001999","obo:HP_0010864","obo:HP_0000518","obo:HP_0002307","obo:HP_0001270","obo:HP_0410263","obo:HP_0000020","obo:HP_0001257","obo:HP_0011968"],"previousTesting":true,"previousTestingDescription":"Normal karyotyping","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:f76c734d-8a22-4e01-97dc-a7ae1fb5fbe1_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:eb2950b6-8311-4cee-92a6-2cdf89892da0"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F29: P1"},{"id":"cggv:f76c734d-8a22-4e01-97dc-a7ae1fb5fbe1","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:f76c734d-8a22-4e01-97dc-a7ae1fb5fbe1_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":6.7},{"id":"cggv:1a339905-1a73-4f04-9bfa-6f76e2340412_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:1a339905-1a73-4f04-9bfa-6f76e2340412","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"detectionMethod":"Only Sanger sequencing was done for MED27(NM_004269.4):c.871G>A ","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001249","obo:HP_0000750","obo:HP_0001252","obo:HP_0001263","obo:HP_0003202","obo:HP_0001270","obo:HP_0001260","obo:HP_0000518"],"sex":"Female","variant":{"id":"cggv:03b1b623-1a08-4bb3-8d85-1849c3791006_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F24: P1"},{"id":"cggv:03b1b623-1a08-4bb3-8d85-1849c3791006","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:03b1b623-1a08-4bb3-8d85-1849c3791006_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e7583f8d-38f5-4ffb-9b62-0f2b39be7a1e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e7583f8d-38f5-4ffb-9b62-0f2b39be7a1e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001270","obo:HP_0001260","obo:HP_0000750","obo:HP_0000518","obo:HP_0001251","obo:HP_0002307","obo:HP_0001256","obo:HP_0001263","obo:HP_0001332","obo:HP_0001272","obo:HP_0001999","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"Nomal karyotyping","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:ab4bf4b2-03ca-4080-a92f-061c249919a6_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F30: P1"},{"id":"cggv:ab4bf4b2-03ca-4080-a92f-061c249919a6","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:ab4bf4b2-03ca-4080-a92f-061c249919a6_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f0748fab-e529-420b-8668-6e806305dbb0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f0748fab-e529-420b-8668-6e806305dbb0","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.725T>C (p.Val242Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375683504"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002187","obo:HP_0001252","obo:HP_0001999","obo:HP_0001270","obo:HP_0010864","obo:HP_0000518","obo:HP_0001250","obo:HP_0001332","obo:HP_0000750","obo:HP_0003202","obo:HP_0002307","obo:HP_0001272","obo:HP_0002376","obo:HP_0001263","obo:HP_0001257"],"previousTesting":true,"previousTestingDescription":"HD Affymetrix Cytoscan (2.65M): duplication of ca.1.7 Mb in hg19 chrX:6446579-8135644, 8 Genes, 6 OMIM Genes, segregation analysis showed the same uplication in the 3 healthy siblings + mother; Trio-Wes: NM_033646.2(CDH7):c.[122G>C];[122=] p.[(Gly41Ala)];[Gly41=] hg19 chr18:g.[63430200G>C];[63430200=] het, <f>de novo</f>","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:a20d8959-00cf-4d9f-960e-6208b5fe0957_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F8: P1"},{"id":"cggv:a20d8959-00cf-4d9f-960e-6208b5fe0957","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:a20d8959-00cf-4d9f-960e-6208b5fe0957_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:bc56b184-1712-4294-82ee-a8fb25471393_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bc56b184-1712-4294-82ee-a8fb25471393","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001251","obo:HP_0001256","obo:HP_0002307","obo:HP_0001270","obo:HP_0001332","obo:HP_0001260","obo:HP_0001999","obo:HP_0003202","obo:HP_0000020","obo:HP_0001263","obo:HP_0001272","obo:HP_0001252","obo:HP_0001257","obo:HP_0410263"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:38365ba4-33ba-4752-a6b1-d1484f1d1e04_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F26: P1"},{"id":"cggv:38365ba4-33ba-4752-a6b1-d1484f1d1e04","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:38365ba4-33ba-4752-a6b1-d1484f1d1e04_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:d9b57a27-85c9-4dff-993b-566e3886d788_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d9b57a27-85c9-4dff-993b-566e3886d788","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":[{"id":"cggv:72cc6135-dc8f-45d4-8bf2-f520195eb465","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.695C>T (p.Ser232Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA200593911"}},{"id":"cggv:64d8a018-c7cb-46b6-8604-1cc8025dd160","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.298_302del (p.Lys100SerfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2581934936"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001999","obo:HP_0001344","obo:HP_0002307","obo:HP_0001332","obo:HP_0001270","obo:HP_0002540","obo:HP_0010808","obo:HP_0001252","obo:HP_0001272","obo:HP_0001263","obo:HP_0001257","obo:HP_0010864"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:70ca2e84-242b-48f1-8450-d4853e24cf9d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:72cc6135-dc8f-45d4-8bf2-f520195eb465"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},{"id":"cggv:1393133f-1a66-4103-a290-c3b71cf24198_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:64d8a018-c7cb-46b6-8604-1cc8025dd160"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"}],"rdfs:label":"7"},{"id":"cggv:70ca2e84-242b-48f1-8450-d4853e24cf9d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:70ca2e84-242b-48f1-8450-d4853e24cf9d_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:1393133f-1a66-4103-a290-c3b71cf24198","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:1393133f-1a66-4103-a290-c3b71cf24198_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0991d006-6a02-4ac6-84d6-576b32ce58aa_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0991d006-6a02-4ac6-84d6-576b32ce58aa","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001344","obo:HP_0001270","obo:HP_0010864","obo:HP_0003202","obo:HP_0001263","obo:HP_0001272","obo:HP_0001999","obo:HP_0000750","obo:HP_0001257","obo:HP_0000518","obo:HP_0001276","obo:HP_0001251","obo:HP_0001250","obo:HP_0002540"],"previousTesting":true,"previousTestingDescription":"Chromosome analysis, DNA-SNP-array, methylation specific MLPA of the region 15q11-13, and sequence analysis of MECP2 and CTDP1 gave unremarkable results","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:5bdeebda-1ed3-4e17-8cac-b9af067ba7b3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F23: P1"},{"id":"cggv:5bdeebda-1ed3-4e17-8cac-b9af067ba7b3","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:5bdeebda-1ed3-4e17-8cac-b9af067ba7b3_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:047ddb5c-80c8-490d-a464-ce8d514d4264_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:047ddb5c-80c8-490d-a464-ce8d514d4264","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001257","obo:HP_0001263","obo:HP_0009830","obo:HP_0001272","obo:HP_0000518","obo:HP_0001252","obo:HP_0010864","obo:HP_0001250","obo:HP_0002540","obo:HP_0000252","obo:HP_0001332","obo:HP_0033725","obo:HP_0002376","obo:HP_0001344","obo:HP_0001270"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:49f101be-db06-4808-819e-c28000f355aa_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},"rdfs:label":"3-1"},{"id":"cggv:49f101be-db06-4808-819e-c28000f355aa","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:49f101be-db06-4808-819e-c28000f355aa_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":3},{"id":"cggv:e9f1db79-4368-48b2-8584-8f0be40ee816_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e9f1db79-4368-48b2-8584-8f0be40ee816","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002307","obo:HP_0410263","obo:HP_0001257","obo:HP_0000518","obo:HP_0000750","obo:HP_0003202","obo:HP_0001276","obo:HP_0001260","obo:HP_0002376","obo:HP_0001324","obo:HP_0001332","obo:HP_0001249","obo:HP_0001263","obo:HP_0001270"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:d91d7016-5fea-4f16-98c4-171b2a8b8270_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F28: P1"},{"id":"cggv:d91d7016-5fea-4f16-98c4-171b2a8b8270","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:d91d7016-5fea-4f16-98c4-171b2a8b8270_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:1a567f1c-ce97-4bd8-9da6-d4b1ec60f626_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:1a567f1c-ce97-4bd8-9da6-d4b1ec60f626","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0000518","obo:HP_0001332","obo:HP_0009879","obo:HP_0002540","obo:HP_0001252","obo:HP_0001270","obo:HP_0001344","obo:HP_0001257","obo:HP_0001263","obo:HP_0002187","obo:HP_0001999","obo:HP_0002307","obo:HP_0001272","obo:HP_0002015"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:f1faf105-f2fb-49c2-af0b-b34f0de844fe_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},"rdfs:label":"4"},{"id":"cggv:f1faf105-f2fb-49c2-af0b-b34f0de844fe","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:f1faf105-f2fb-49c2-af0b-b34f0de844fe_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:233a1239-926e-4c98-87b2-e5c6e0ef297c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:233a1239-926e-4c98-87b2-e5c6e0ef297c","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Formal testing for intellectual disability not yet performed, severe developmental delay","phenotypes":["obo:HP_0001270","obo:HP_0001332","obo:HP_0000252","obo:HP_0410263","obo:HP_0002540","obo:HP_0001344","obo:HP_0001999","obo:HP_0001257","obo:HP_0001250","obo:HP_0000518","obo:HP_0001276","obo:HP_0001263","obo:HP_0001272","obo:HP_0002376","obo:HP_0003202"],"previousTesting":true,"previousTestingDescription":"WES and Sanger sequencing has been done for homozygous MED27(NM_001253881) c.617T>C and homozygous ENTPD1(NM_001164178.1):c.1400T>C (ENTPD1 is classified 'Definitive' for complex hereditary spastic paraplegia)","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:dc58650b-cb15-4167-9f3b-5732cf12c4c8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F25: P1"},{"id":"cggv:dc58650b-cb15-4167-9f3b-5732cf12c4c8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:dc58650b-cb15-4167-9f3b-5732cf12c4c8_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:eb298184-8624-4144-9ee2-81ff66d69c28_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:eb298184-8624-4144-9ee2-81ff66d69c28","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001332","obo:HP_0001251","obo:HP_0002307","obo:HP_0001272","obo:HP_0000518","obo:HP_0030842","obo:HP_0001260","obo:HP_0001263","obo:HP_0001270","obo:HP_0001999","obo:HP_0000750","obo:HP_0001252","obo:HP_0001249"],"previousTesting":true,"previousTestingDescription":"WES - Homozygous Variant in ERCC6 c.3745G>A; p.Asp1249Asn. Familial segregation not yet performed. Normal CMA ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:6bbd13c2-fd3b-4fa2-8545-5f4e3f80ffb0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d8562197-336f-4448-8aee-b998f2cc79ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F7: P1"},{"id":"cggv:6bbd13c2-fd3b-4fa2-8545-5f4e3f80ffb0","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:6bbd13c2-fd3b-4fa2-8545-5f4e3f80ffb0_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:5657bbf6-85b0-4838-834a-20a653f81af0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:5657bbf6-85b0-4838-834a-20a653f81af0","type":"Proband","ageUnit":"Years","ageValue":11,"allele":{"id":"cggv:dca5085a-f363-458c-b588-e2089b972e22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.814A>C (p.Ser272Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375682136"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0410263","obo:HP_0002540","obo:HP_0001270","obo:HP_0001263","obo:HP_0002307","obo:HP_0002187","obo:HP_0000020","obo:HP_0001250","obo:HP_0001257","obo:HP_0000518","obo:HP_0001272","obo:HP_0001332","obo:HP_0003202","obo:HP_0001344","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"WES negative","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:dc23c3bc-0ed1-4f29-9a16-4e54c71dc10d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:dca5085a-f363-458c-b588-e2089b972e22"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F5: P1"},{"id":"cggv:dc23c3bc-0ed1-4f29-9a16-4e54c71dc10d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:dc23c3bc-0ed1-4f29-9a16-4e54c71dc10d_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:b4c621fa-afec-45e5-be85-b9affc503718_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b4c621fa-afec-45e5-be85-b9affc503718","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":{"id":"cggv:f89c7fb4-6a85-4f72-9d92-6c974db2d3c6"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0001332","obo:HP_0001250","obo:HP_0003202","obo:HP_0002342","obo:HP_0001272","obo:HP_0000252","obo:HP_0001999","obo:HP_0410263","obo:HP_0002540","obo:HP_0001344","obo:HP_0001270","obo:HP_0000518"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:9174380b-d3a9-4767-a5b6-2d0ed5ce0bf8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f89c7fb4-6a85-4f72-9d92-6c974db2d3c6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F3: P1"},{"id":"cggv:9174380b-d3a9-4767-a5b6-2d0ed5ce0bf8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:9174380b-d3a9-4767-a5b6-2d0ed5ce0bf8_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:eb54294a-c839-4b3a-bc9a-dd29e6dca3ac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:eb54294a-c839-4b3a-bc9a-dd29e6dca3ac","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"cggv:602002fd-8d95-4355-948c-a1744c76badb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.878C>T (p.Pro293Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375681994"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001310","obo:HP_0000750","obo:HP_0000518","obo:HP_0001272","obo:HP_0002342","obo:HP_0002376","obo:HP_0001263","obo:HP_0001252","obo:HP_0034671","obo:HP_0001270","obo:HP_0001999"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:d42c857c-e148-45df-86a5-d80cbcded4ca_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:602002fd-8d95-4355-948c-a1744c76badb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},"rdfs:label":"10-1"},{"id":"cggv:d42c857c-e148-45df-86a5-d80cbcded4ca","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:d42c857c-e148-45df-86a5-d80cbcded4ca_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:4889f570-95df-4c64-9610-68d503d17bb0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:4889f570-95df-4c64-9610-68d503d17bb0","type":"Proband","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":9,"allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002342","obo:HP_0001270","obo:HP_0410263","obo:HP_0000252","obo:HP_0001250","obo:HP_0001272","obo:HP_0002376","obo:HP_0001263","obo:HP_0000750","obo:HP_0000518"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:2592945c-c8a6-48b5-b0ef-9874c42f7a51_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:54425f3b-7a4e-4be8-873e-20c70a366c20"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F22: P1"},{"id":"cggv:2592945c-c8a6-48b5-b0ef-9874c42f7a51","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:2592945c-c8a6-48b5-b0ef-9874c42f7a51_variant_evidence_item"}],"strengthScore":0,"dc:description":"Not scored as this proband has the same genotype as an already scored proband. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f3ba60d7-6130-4a0c-8804-c507ffff27e3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f3ba60d7-6130-4a0c-8804-c507ffff27e3","type":"Proband","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":2,"allele":{"id":"cggv:8c23a235-3811-42cb-9b0c-68e94c4fef00","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.818A>G (p.Tyr273Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375682125"}},"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"Microarray: Excess homozygosity.\nPOMT1, POMT2, FKTN & ERCC6 genes sequencing: all negative.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:61b4da82-b6cd-4189-afad-9fe9e5f5061f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:8c23a235-3811-42cb-9b0c-68e94c4fef00"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37517035"},"rdfs:label":"F6: P1"},{"id":"cggv:61b4da82-b6cd-4189-afad-9fe9e5f5061f","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:61b4da82-b6cd-4189-afad-9fe9e5f5061f_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Maximum of 0.1 pt per proband, homozygous for a non-null allele"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f5329892-190f-4241-bfad-f5b250bd5114_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f5329892-190f-4241-bfad-f5b250bd5114","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":20,"allele":[{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},{"id":"cggv:cfa820fe-7c74-423c-aa69-3cc7ff14e72d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004269.4(MED27):c.565_566del (p.Met189AlafsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA200621897"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002019","obo:HP_0001999","obo:HP_0002119","obo:HP_0001270","obo:HP_0001344","obo:HP_0001601","obo:HP_0001332","obo:HP_0033725","obo:HP_0010808","obo:HP_0000518","obo:HP_0008619","obo:HP_0001252","obo:HP_0001272","obo:HP_0001263","obo:HP_0000252","obo:HP_0001257","obo:HP_0001250","obo:HP_0002015","obo:HP_0002870","obo:HP_0010536"],"previousTestingDescription":"Unspecified: \"Prior to ES analysis, most reported patients had extensive clinical, metabolic, and genetic investigations, yet had not received a molecular diagnosis.\" ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:9e7340b9-67b7-447d-9518-80154ce86939_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a5fe7aa-355d-49f0-93b1-510fd04304ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"},{"id":"cggv:f3026184-211c-4e1e-ba80-0a93a0adc888_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cfa820fe-7c74-423c-aa69-3cc7ff14e72d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/33443317"}],"rdfs:label":"5"},{"id":"cggv:9e7340b9-67b7-447d-9518-80154ce86939","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:9e7340b9-67b7-447d-9518-80154ce86939_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:f3026184-211c-4e1e-ba80-0a93a0adc888","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:f3026184-211c-4e1e-ba80-0a93a0adc888_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9.7},{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:79dac5d0-fd8e-4e7a-8c72-2f1a1d159dd8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:aaab4aac-212f-4845-8e9a-8713636297bf","type":"Finding","demonstrates":{"id":"obo:MI_0915"},"dc:description":"MED27 was isolated and characterized in Ryu et al., PMID 9989412 as part of the mediator complex, necessary for transcriptional activation, after which the other mediator complex components have been identified and described.\n\nThe mediator complex is made up of a head, middle, tail and CDK-kinase module. MED12, MED13, MED13L and CDK8 make up the CDK-kinase module. MED17 is a subunit of the head module. MED25 and MED27 make up subunits of the tail module.\n\nMED12 is 'definitively' associated with intellectual disability syndrome (ClinGen). MED13 is 'definitively' associated with complex neurodevelopmental disorder (including global developmental, language and motor delay and intellectual disability) (ClinGen). MED13L is 'definitively' associated with syndromic intellectual disability (including global developmental, language and motor delay and seizures) (ClinGen). MED17 is associated with infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly with classifications of 'strong' (GenCC: G2P, Invitae) and 'supportive' (GenCC: Orphanet). MED25 is associated with congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome with classifications of 'definitive' (GenCC: G2P), and 'moderate' (GenCC: Ambry). CDK8 is associated with intellectual developmental disorder with hypotonia and behavioral abnormalities with classifications of 'strong' (Invitae) and 'moderate' (Ambry)","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/37516429","type":"dc:BibliographicResource","dc:abstract":"Neurological diseases, including traumatic brain injuries, stroke (haemorrhagic and ischemic), and inherent neurodegenerative diseases cause acquired disability in humans, representing a leading cause of death worldwide. The Mediator complex (MED) is a large, evolutionarily conserved multiprotein that facilities the interaction between transcription factors and RNA Polymerase II in eukaryotes. Some MED subunits have been found altered in the brain, although their specific functions in neurodegenerative diseases are not fully understood. Mutations in MED subunits were associated with a wide range of genetic diseases for MED12, MED13, MED13L, MED20, MED23, MED25, and CDK8 genes. In addition, MED12 and MED23 were deregulated in the Alzheimer's Disease. Interestingly, most of the genomic mutations have been found in the subunits of the kinase module. To date, there is only one evidence on MED1 involvement in post-stroke cognitive deficits. Although the underlying neurodegenerative disorders may be different, we are confident that the signal cascades of the biological-cognitive mechanisms of brain adaptation, which begin after brain deterioration, may also differ. Here, we analysed relevant studies in English published up to June 2023. They were identified through a search of electronic databases including PubMed, Medline, EMBASE and Scopus, including search terms such as \"Mediator complex\", \"neurological disease\", \"brains\". Thematic content analysis was conducted to collect and summarize all studies demonstrating MED alteration to understand the role of this central transcriptional regulatory complex in the brain. Improved and deeper knowledge of the regulatory mechanisms in neurological diseases can increase the ability of physicians to predict onset and progression, thereby improving diagnostic care and providing appropriate treatment decisions.","dc:creator":"Schiano C","dc:date":"2023","dc:title":"Mediator complex in neurological disease."},"rdfs:label":"MED27 interacts with proteins involved in similar disease"}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1,"dc:description":"There are â¥3 proteins with the same function that are involved in the same/similar disease"},{"id":"cggv:314f14bf-e1e1-4f27-ab1d-28ab83e609bf","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:3727282e-de60-460e-ab3a-1e1543346593","type":"Finding","demonstrates":{"id":"cg:BiochemicalFunctionA"},"dc:description":"The mediator complex is made up of a head, middle, tail and CDK-kinase module. MED12, MED13, MED13L and CDK8 make up the CDK-kinase module. MED17 is a subunit of the head module. MED25 and MED27 make up subunits of the tail module.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37516429","rdfs:label":"MED27 is a subunit of the mediator complex"}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1,"dc:description":"There are â¥3 proteins with the same function that are involved in the same/similar disease"}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:f6593414-5d83-4f9c-93c5-2e8399963d35","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:eb597f70-84a2-488d-9988-c09dc65455fb","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"As an experimental system, the authors chose the developing zebrafish retina, since it represents one of the best-studied units of the CNS and allows detection of developmental defects at high resolution. Mutant zebrafish showed a reduction in head size when compared to wild-type and abnormal neurological development, phenotypes of humans with the condition. ","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/16582438","type":"dc:BibliographicResource","dc:abstract":"The transcriptional mediator complex has emerged as an important component of transcriptional regulation, yet it is largely unknown whether its subunits have differential functions in development. We demonstrate that the zebrafish mutation m885 disrupts a subunit of the mediator complex, Crsp34/Med27. To explore the role of the mediator in the control of retinal differentiation, we employed two additional mutations disrupting the mediator subunits Trap100/Med24 and Crsp150/Med14. Our analysis shows that loss of Crsp34/Med27 decreases amacrine cell number, but increases the number of rod photoreceptor cells. In contrast, loss of Trap100/Med24 decreases rod photoreceptor cells. Loss of Crsp150/Med14, on the other hand, only slightly reduces dopaminergic amacrine cells, which are absent from both crsp34(m885) and trap100(lessen) mutant embryos. Our data provide evidence for differential requirements for Crsp34/Med27 in developmental processes. In addition, our data point to divergent functions of the mediator subunits Crsp34/Med27, Trap100/Med24, and Crsp150/Med14 and, thus, suggest that subunit composition of the mediator contributes to the control of differentiation in the vertebrate CNS.","dc:creator":"DÃ¼rr K","dc:date":"2006","dc:title":"Differential roles of transcriptional mediator complex subunits Crsp34/Med27, Crsp150/Med14 and Trap100/Med24 during zebrafish retinal development."},"rdfs:label":"MED27 Knockout Zebrafish Model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5,"dc:description":"-1: Model does not recapitulate all phenotypes associated with this condition.\n-0.5: Rescue is not a human allele, but a zebrafish allele"},{"id":"cggv:d92a5b0d-d320-446f-b5ee-9cdd76389743","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:60fade32-2a35-47d3-93ba-98acffd4d677","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Death before adulthood was seen in 16% of cases","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/31613003","type":"dc:BibliographicResource","dc:abstract":"Transgenic birds are commonly used for time-lapse imaging and fate mapping studies in developmental biology. When researchers use transgenic birds expressing fluorescent protein, they need to understand the integration site of the transgene in the genome and the intensity of fluorescence in the tissues of interest. In this study, we determined the integration site of the transgene and fluorescence property of developing organs in our transgenic chicken line generated by lentivirus infection. The transgene was localized between exons 3 and 4 of MED27. Some homozygotes and heterozygotes appeared to be lethal at early embryonic stages. We performed histological analysis of EGFP expression in transgenic embryos at St. 14, 17, and 24 by immunohistochemistry with anti-GFP antibody on paraffin sections. Next, we cut cryosections and quantified direct EGFP intensity from the transgene in each tissue without performing immunohistochemistry. These results revealed that EGFP intensity in each tissue was unique in developing embryos and changed according to developmental stages. Finally, we demonstrated that EGFP-expressing cells in a micromass culture with co-culturing wild-type cells were clearly distinguishable via live cell imaging. These results provide essential information on the potential of our transgenic line and indicate that these transgenic chicken lines are useful for research associated with developmental biology.","dc:creator":"Tsujino K","dc:date":"2019","dc:title":"Identification of transgene integration site and anatomical properties of fluorescence intensity in a EGFP transgenic chicken line."},"rdfs:label":"MED27 Knockout Chicken Model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0,"dc:description":"Chicken model does not recapitulate the disease phenotype: lethality. However, no human cases that are homozygous or compound heterozygous for loss-of-function variants have been reported, suggesting that complete loss of function may be embryonically lethal. "},{"id":"cggv:08dcbeb1-355c-44f4-9204-62d2f4f4a9b2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:8063bb91-b224-4ecc-9734-e02a975cc93a","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Death before adulthood was seen in 16% of cases","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/36305825","type":"dc:BibliographicResource","dc:abstract":"The International Mouse Phenotyping Consortium (IMPC; https://www.mousephenotype.org/) web portal makes available curated, integrated and analysed knockout mouse phenotyping data generated by the IMPC project consisting of 85M data points and over 95,000 statistically significant phenotype hits mapped to human diseases. The IMPC portal delivers a substantial reference dataset that supports the enrichment of various domain-specific projects and databases, as well as the wider research and clinical community, where the IMPC genotype-phenotype knowledge contributes to the molecular diagnosis of patients affected by rare disorders. Data from 9,000 mouse lines and 750 000 images provides vital resources enabling the interpretation of the ignorome, and advancing our knowledge on mammalian gene function and the mechanisms underlying phenotypes associated with human diseases. The resource is widely integrated and the lines have been used in over 4,600 publications indicating the value of the data and the materials.","dc:creator":"Groza T","dc:date":"2023","dc:title":"The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease."},"rdfs:label":"MED27 Knockout Mouse Model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0,"dc:description":"Mouse model does not recapitulate the disease phenotype: pre-weaning lethality. However, no human cases that are homozygous or compound heterozygous for loss-of-function variants have been reported, suggesting that complete loss of function may be embryonically lethal. "},{"id":"cggv:141c7e79-cc3b-4d15-819f-325cfa06d274","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:ebc04c29-4ec6-4d5b-8b19-ecc2bbd243be","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Death before adulthood was seen in 16% of cases","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30091705","type":"dc:BibliographicResource","dc:abstract":"We generated two new genetic tools to efficiently tag genes in ","dc:creator":"Li-Kroeger D","dc:date":"2018","dc:title":"An expanded toolkit for gene tagging based on MiMIC and scarless CRISPR tagging in "},"rdfs:label":"MED27 Knockout Drosophila Model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0,"dc:description":"Drosophila model does not recapitulate the disease phenotype. Deletion of Med27 is pupal lethal. However, no human cases that are homozygous or compound heterozygous for loss-of-function variants have been reported, suggesting that complete loss of function may be embryonically lethal. "}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Strong","sequence":8117,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.2,"subject":{"id":"cggv:71a4e234-f9d2-4503-8437-8f419fc1ae31","type":"GeneValidityProposition","disease":"obo:MONDO_0859137","gene":"hgnc:2377","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"The *MED27* gene is located on chromosome 9 at 9q34.13 and encodes a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation (PMID 9989412). *MED27* was first reported in relation to autosomal recessive neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia in 2021 (Meng et al., PMID: 33443317). Sixteen variants (11 missense, 1 in-frame indel, 3 frameshift and 1 splicing) that have been reported in 30 probands in two publications (PMIDs: 33443317, 37517035) are included in this curation. Variants in this gene segregated with disease in families with multiple affected family members. The mechanism of pathogenicity is reported to be loss of function (PMID: 16582438). â\n\nThis gene-disease relationship is also supported by experimental evidence (biochemical, protein interactions and animal models) (PMIDs: 9989412, 37516429, 16582438, 36305825, 30091705, 31613003). Other genes that code for mediator complex subunits (*MED12*, *MED13*, *MED13L*, *MED17*, *MED25* and *CDK8*) are definitively or strongly associated with conditions involving developmental, language and motor delay, intellectual disability, seizures, cataracts and microcephaly. A knockout zebrafish model showed a reduction in head size and abnormal neurological development (PMID 16582438). Early lethality was observed in *MED27* gene knockouts in mouse, fruit fly and chicken (PMIDs: 36305825, 30091705, 31613003). While these latter three models do not necessarily recapitulate the disease phenotype, the observation that no reported human cases have been homozygous or compound heterozygous for loss-of-function variants suggests that complete loss of function of MED27 may be embryonically lethal. \n\nIn summary, there is strong evidence to support the relationship between *MED27* and autosomal recessive neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia. Three years must elapse from the first proposal of the assertion to reach a definitive classification without any valid contradictory evidence. We will re-evaluate this gene-disease relationship at that time to determine if an upgraded classification of definitive is warranted. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date 12/15/2023 (SOP Version 10). ","dc:isVersionOf":{"id":"cggv:58234a0f-9c8b-432f-9397-815ccfae66fc"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}